A cost analysis of functional bowel disorders in Iran

International Journal of Colorectal Disease

Volumn 22, Issue 7, 2007, Pages 791-799

  Roshandel, Delnaz ^a   Rezailashkajani, Mohammadreza ^a   Shafaee, Sepideh ^a   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Colonic diseases; Cost analysis; Economics; Functional; Functional bowel disorder; Irritable bowel syndrome; Medical

Indexed keywords

ANTIBIOTIC AGENT; BISMUTH; CLIDINIUM; HERBACEOUS AGENT; METRONIDAZOLE;

ARTICLE; BLOATING; CONSTIPATION; CONSULTATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DRUG COST; FREQUENCY ANALYSIS; GASTROENTEROLOGY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; INTERVIEW; INTESTINE FUNCTION DISORDER; IRAN; IRRITABLE COLON; JOB PERFORMANCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL CARE; OUTPATIENT; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRODUCTIVITY; QUESTIONNAIRE; SOCIOECONOMICS; SYMPTOM; URBAN POPULATION;

ADULT; COSTS AND COST ANALYSIS; HEALTH CARE COSTS; HUMANS; INTESTINAL DISEASES; IRAN; OUTPATIENTS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS;

EID: 34249875412     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-006-0226-2     Document Type: Article

References (29)

1. Thompson WG, Longstreth GF, Drossman DA et al (1999) Functional bowel disorders and functional abdominal pain. Gut 45(Supp1 II):II43-II47
2. Thompson WG, Irvine EJ, Pare P et al (2002) Functional gastrointestinal disorders in Canada: First population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 47(1):225-235 (Jan)
3. Sperber AD, Shvartzman P, Friger M, Fich A (2005) Unexpectedly low prevalence rates of IBS among adult Israeli Jews. Neurogastroenterol Motil 17(2):207-211 (Apr)
4. Hoseini-Asl MK, Amra B (2003) Prevalence of irritable bowel syndrome in Shahrekord, Iran. Indian J Gastroenterol 22(6):215-216 (Nov-Dec)
5. Dapoigny M, Bellanger J, Bonaz B et al (2004) Irritable bowel syndrome in France: A common, debilitating and costly disorder. Eur J Gastroenterol Hepatol 16(10):995-1001 (Oct)
6. Badia X, Mearin F, Balboa A et al (2002) Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics 20(11):749-758
7. Dean BB, Aguilar D, Barghout V et al (2005) Impairment in work productivity and health-related quality of life in patients with IBS. Am J Manag Care 11(1 Suppl):S17-S26 (Apr)
8. Muller-Lissner SA, Pirk O (2002) Irritable bowel syndrome in Germany. A cost of illness study. Eur J Gastroenterol Hepatol 14(12):1325-1329 (Dec)
9. Le Pen C, Ruszniewski P, Gaudin AF et al (2004) The burden cost of French patients suffering from irritable bowel syndrome. Scand J Gastroenterol 39(4):336-343 (Apr)
10. Leong SA, Barghout V, Birnbaum HG et al (2003) The economic consequences of irritable bowel syndrome: A US employer perspective. Arch Intern Med 163(8):929-935 (Apr 28)
11. Longstreth GF, Wilson A, Knight K et al (2003) Irritable bowel syndrome, health care use, and costs: A U.S. managed care perspective. Am J Gastroenterol 98(3):600-607 (Mar)
12. Akehurst RL, Brazier JE, Mathers N et al (2002) Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics 20(7):455-462
13. Patel RP, Petitta A, Fogel R et al (2002) The economic impact of irritable bowel syndrome in a managed care setting. J Clin Gastroenterol 35(1):14-20 (Jul)
14. Levy RL, Von Korff M, Whitehead WE et al (2001) Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol 96(11):3122-3129 (Nov)
15. Akehurst RL, Brazier JE, Mathers N et al (2002) Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics 20(7):455-462
16. Pare P, Ferrazzi S, Thompson WG et al (2001) An epidemiological survey of constipation in canada: Definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol 96(11): 3130-3137 (Nov)
17. Garrigues V, Galvez C, Ortiz V et al (2004) Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain. Am J Epidemiol 159(5):520-526 (Mar 1)
18. Pekmezaris R, Aversa L, Wolf-Klein G et al (2002) The cost of chronic constipation. J Am Med Dir Assoc 3(4):224-228 (Jul-Aug)
19. Roshandel D, Rezailashkajani M, Shafaee S, Zali MR (2006) Symptom patterns and relative distribution of functional bowel disorders in 1,023 gastroenterology patients in Iran. Int J Colorectal Dis 21(8):814-825
20. Kwan AC, Bao TN, Chakkaphak S, Chang FY, Ke MY, Law NM, Leelakusolvong S, Luo JY, Manan C, Park HJ, Piyaniran W, Qureshi A, Long T, Xu GM, Xu L, Yuen H (2003) Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample. J Gastroenterol Hepatol 18(7):796-802 (Jul)
21. Boyce PM, Koloski NA, Talley NJ (2000) Irritable bowel syndrome according to varying diagnostic criteria: Are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol 95(11):3176-3183 (erratum in Am J Gastroenterol 96(4):1319)
22. Talley NJ, Zinsmeister AR, Melton LJ 3rd (1995) Irritable bowel syndrome in a community: Symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 142(1):76-83 (Jul 1)
23. Inadomi JM, Fennerty MB, Bjorkman D (2003) Systematic review: The economic impact of irritable bowel syndrome. Aliment Pharmacol Ther 18:671-682
24. Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R (2006) Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 24(1):21-37
25. Bentkover JD, Field C, Greene EM, Plourde V, Casciano JP (1999) The economic burden of irritable bowel syndrome in Canada. Can J Gastroenterol 13(Suppl A):89A-96A
26. Ghannadi K, Emami R, Bashashati M et al (2005) Irritable bowel syndrome: an epidemiological study from the west of Iran. Indian J Gastroenterol 24(5):225-226 (Sep-Oct)
27. Massarrat S, Saberi-Firoozi M, Soleimani A et al (1995) Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol 7(5):427-433 (May)
28. Khoshbaten M, Hekmatdoost A, Ghasemi H, Entezariasl M (2004) Prevalence of gastrointestinal symptoms and signs in northwestern Tabriz, Iran. Indian J Gastroenterol 23(5):168-170 (Sep-Oct)
29. Harris LA (2005) Prevalence and ramifications of chronic constipation. Manag Care Interface 18(8):23-30 (Aug)